(Q43816249)

27 November 2017

The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models (English)

1 reference

27 November 2017

0 references

0 references

0 references

0 references

S R Smith

1

1 reference

27 November 2017

G Denhardt

series ordinal

2

1 reference

27 November 2017

C Terminelli

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

European Journal of Pharmacology

27 November 2017

1 reference

27 November 2017

432

1 reference

27 November 2017

107-119

1 reference

27 November 2017

1

1 reference

Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

Neutrophil migration induced by staphylococcal enterotoxin type A in mice: a pharmacological analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

Opioid receptors on bone marrow neutrophils modulate chemotaxis and CD11b/CD18 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

Suppression of human macrophage function in vitro by delta 9-tetrahydrocannabinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

Macrophages and mesothelial cells in bacterial peritonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

inferred from DOI database lookup

7 January 2021

based on heuristic

In vivo effect of staphylococcal enterotoxin A on peripheral blood lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901477-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01477-7

1 reference

27 November 2017

1 reference